Deep Dive In Vitiligo

The Jackson-Thomas-Harlow Effect describes how visibility, storytelling, and cultural representation can reshape public understanding of vitiligo.

In this episode of Deep Dive in Vitiligo, we look at how:

We also discuss how World Vitiligo Day transformed that visibility into a global advocacy movement — connecting patients, doctors, researchers, and communities around the world.

A sharp look at medicine, media, and why human faces often change minds faster than facts. 🎙️

📚 Prefer reading to listening? The full companion article, The Jackson, Thomas, Harlow Effect on Vitiligo is available on the VRF website and expands on many of the themes discussed in this episode.

Google sees billions of searches. But what if, for one day, it helped the world see vitiligo?

In this episode of Deep Dive in Vitiligo, we explore the renewed campaign to bring a Google Doodle to World Vitiligo Day on June 25, 2026.

Past attempts did not succeed. This year, the strategy shifts from emotional appeals to raw tech logistics. We discuss how the vitiligo community is mobilizing for a coordinated digital push with one simple goal: feed Google’s automated intake systems with enough structured public signal.

By saturating the web with a clear, unified message linking “World Vitiligo Day” directly to “Google Doodle,” the campaign aims to make the connection impossible to miss — and shine a literal ray of light onto a community that has spent too long in the shadows.

From WVD’s grassroots beginnings in 2011 to its 2026 return to Chandigarh under the theme “From Stigma to Strength,” this is a story about symbols, recognition, and a patient community learning how to speak the language of the platforms that shape visibility today.

Continue reading:

After a brief hiatus, the Deep Dive in Vitiligo podcast returns with a packed lineup of new episodes covering vitiligo science, lifestyle, advocacy, and technology.

In this update, Yan Valle explains where the podcast has been, why AI didn’t save nearly as much time as promised, and what’s coming next—including

The voices may be AI. The research, writing, editing, and judgment remain entirely human.

Subscribe now and join us for a new season of conversations at the intersection of skin, science, technology, and the human experience.

In this closing 2025 episode, we unpack four decades of National Institute of Health (NIH) data, compare vitiligo’s budget to other autoimmune and skin diseases, and explain the “industry twist”: tiny public dollars helped build the science, while the commercial market is now booming.

We also look at the big paradox: vitiligo research helped spark major ideas in modern medicine (think immune pathways that later shaped blockbuster therapies), yet the shared infrastructure vitiligo now needs — US-based biobanks, registries, and longitudinal cohorts — remains fragmented. Meanwhile, the commercial side is moving fast, with a billion-dollar market and crowded pipelines.

Read the full report in two parts:

The Vitiligo Paradox – Common Disease, Rare Funding

Who Gets to Do Vitiligo Science?

In this year-end episode, we walk through what VRF built in 2025 — from global advocacy and new research to education, AI support tools, and community partnerships — plus the uncomfortable truths that shaped our priorities for 2026.

Read the full report here: https://vrfoundation.org/news_items/vr-foundation-2025-year-end-report

Vitiligo may show up on your skin, but the drama starts lower down — in your gut, where trillions of microbes run the show. When that microscopic circus gets out of tune, your immune system can lose its mind.

Enter sucralose — that “harmless” fake sugar in your diet soda and protein shake. It tastes sweet, promises zero calories, and might just be quietly gaslighting your gut bacteria. The result? More inflammation, less balance, and a very confused immune system.

In this episode:

Your gut’s a garden, not a chemistry set. Sucralose won’t nuke it overnight — but it might slowly evict the good tenants and hand the keys to the troublemakers.

Full story: Sucralose, Your Gut, and Vitiligo – Should We Worry?

From Easter Island soil to modern skin science — meet rapamycin, the molecule that might just change vitiligo care.

Once known mainly as an anti-rejection drug for organ transplants, rapamycin is now being tested as a topical treatment that could both calm the immune attack and help pigment return. Early studies look promising: minimal side effects, slow but steady repigmentation, and surprisingly good tolerance.

In this episode, we explore:

It’s too early to call it a breakthrough — but this little molecule from a far-off island might just be the next quiet revolution in vitiligo therapy.

Full story: Topical Rapamycin: Could This Be Vitiligo’s Next Big Breakthrough?

Vitiligo isn’t just skin deep — it’s a full-body story. Almost half of those living with it also face anxiety or depression, tied together by the same stress circuits that link the brain and the skin.

In this episode, we dive into how antidepressants affect both body and mind — and why that matters for vitiligo care.

You’ll hear:

A grounded look at the skin–brain connection — and how healing the mind can help the skin follow.

Full story: Vitiligo and Mental Health: How Antidepressants May Shape the Body

What happens when a diagnosis becomes a movement?

In this episode, we follow vitiligo’s unlikely journey from clinic charts to concert stages — a story painted in art, music, film, and unapologetic self-expression. From rickshaw parades in Chandigarh to AI-generated portraits in Toronto and a wax figure at Madame Tussauds New York, creativity has become the heartbeat of World Vitiligo Day.

You’ll hear:

This isn’t just about skin. It’s about courage, culture, and the wild power of creativity.

Where science meets emotion. Where pigment becomes poetry. Where millions stand up and say — this is me.

Full story: Vitiligo — A Global Creative Uprising

When we launched vitiligo.ai back in 2023, the idea was simple: make reliable information about vitiligo available to anyone, anywhere, in any language. What could possibly go wrong, right?

Fast forward two years — turns out AI can sound smart, act caring, and still be utterly clueless. It imitates empathy but doesn’t actually care. It oozes confidence but often has no idea what it’s talking about.

In this episode, Yan Valle — professor, researcher, and the slightly obsessive nerd behind vitiligo.ai — shares what really happens when you try to teach a machine to teach medicine. The wins, the fails, and the very human mess in between.

You’ll hear:

AI is brilliant at answering questions — just not always the right ones.

This episode is a reminder that intelligence is easy to fake. Humanity isn’t.

Here's the long read